Rosetta Inpharmatics' Unattributed VC Round

Rosetta Inpharmatics raised a round of funding on April 19, 1999.

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.…

Articles about Rosetta Inpharmatics' Unattributed VC Round: